Acetylation–ubiquitination crosstalk in NLRP3–gasdermin pyroptosis: a substrate-state framework with relevance to ulcerative colitis
- 1Department of Gastroenterology, Binhai County People’s Hospital
Abstract
Acetylation and ubiquitination regulate inflammatory cell death, but evidence that they act together in ulcerative colitis (UC) remains limited. This review examines their interactions in nucleotide-binding oligomerisation domain-, leucine-rich repeat- and pyrin domain-containing protein 3 (NLRP3) and gasdermin D (GSDMD), drawing on a targeted PubMed search for literature published through 10 August 2026. We distinguish coupling tested within one study from separate mechanisms affecting the same substrate, and report human, intestinal and non-intestinal evidence separately. Studies of phosphoglycerate dehydrogenase, the glucocorticoid-induced tumour necrosis factor receptor and histone deacetylase 4 support acetylation–ubiquitination coupling in non-intestinal systems. These findings differ in site resolution and do not establish competition between the modifications at one lysine. Other studies show that acetylation affects NLRP3 assembly or GSDMD activity, while ubiquitination regulates substrate abundance, assembly and degradation. In experimental colitis, selected NLRP3 ubiquitin pathways and GSDMD acetylation mechanisms influence inflammation, but the complete coupled pathways have not been demonstrated in human UC. We organise these findings around four substrate properties: abundance, activation competence, localisation and persistence. This framework is a descriptive synthesis, not a validated evidence hierarchy or clinical biomarker. Its relevance to UC depends on establishing modification coupling in defined intestinal cell types and distinguishing that coupling from broader anti-inflammatory or barrier-protective effects.
Related
- SMYD3-catalyzed dimethylation of gasdermin D at lysine 43 promotes pyroptosis and inflammatory responses
- Gasdermin D-mediated delivery of caspase inhibitors to suppress pyroptosis
- RNF130 ameliorates renal injury and inflammation by inhibiting macrophage pyroptosis through ubiquitination degradation of PDCD4 in male mice
- Comparative Acetylation and Ubiquitination Profiling in Cervical Cancer-Cell Models Supports a Proposed Lysine-Fate Code
- Crosstalk between ubiquitination and other post-translational modifications in cardiovascular diseases.
BibTeX
@article{zhao2026acetylationubiquitination,
title = {{Acetylation–ubiquitination crosstalk in NLRP3–gasdermin pyroptosis: a substrate-state framework with relevance to ulcerative colitis}},
author = {Yuanyang Zhao and Xiaojie Zhu and Enhui Lu and Hai Meng},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1976894},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1976894/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Acetylation–ubiquitination crosstalk in NLRP3–gasdermin pyroptosis: a substrate-state framework with relevance to ulcerative colitis
AU - Yuanyang Zhao
AU - Xiaojie Zhu
AU - Enhui Lu
AU - Hai Meng
PY - 2026
DA - 2026/10/06
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1976894
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1976894/full
AB - Acetylation and ubiquitination regulate inflammatory cell death, but evidence that they act together in ulcerative colitis (UC) remains limited. This review examines their interactions in nucleotide-binding oligomerisation domain-, leucine-rich repeat- and pyrin domain-containing protein 3 (NLRP3) and gasdermin D (GSDMD), drawing on a targeted PubMed search for literature published through 10 August 2026. We distinguish coupling tested within one study from separate mechanisms affecting the same substrate, and report human, intestinal and non-intestinal evidence separately. Studies of phosphoglycerate dehydrogenase, the glucocorticoid-induced tumour necrosis factor receptor and histone deacetylase 4 support acetylation–ubiquitination coupling in non-intestinal systems. These findings differ in site resolution and do not establish competition between the modifications at one lysine. Other studies show that acetylation affects NLRP3 assembly or GSDMD activity, while ubiquitination regulates substrate abundance, assembly and degradation. In experimental colitis, selected NLRP3 ubiquitin pathways and GSDMD acetylation mechanisms influence inflammation, but the complete coupled pathways have not been demonstrated in human UC. We organise these findings around four substrate properties: abundance, activation competence, localisation and persistence. This framework is a descriptive synthesis, not a validated evidence hierarchy or clinical biomarker. Its relevance to UC depends on establishing modification coupling in defined intestinal cell types and distinguishing that coupling from broader anti-inflammatory or barrier-protective effects.
SN - 1664-3224
ER -